HRP20171227T1 - Upotreba inhibitora vegfr-3 za liječenje hepatocelularnog karcinoma - Google Patents
Upotreba inhibitora vegfr-3 za liječenje hepatocelularnog karcinoma Download PDFInfo
- Publication number
- HRP20171227T1 HRP20171227T1 HRP20171227TT HRP20171227T HRP20171227T1 HR P20171227 T1 HRP20171227 T1 HR P20171227T1 HR P20171227T T HRP20171227T T HR P20171227TT HR P20171227 T HRP20171227 T HR P20171227T HR P20171227 T1 HRP20171227 T1 HR P20171227T1
- Authority
- HR
- Croatia
- Prior art keywords
- hepatocellular carcinoma
- compound
- vegfr
- inhibitors
- treating hepatocellular
- Prior art date
Links
- 206010073071 hepatocellular carcinoma Diseases 0.000 title claims 2
- 231100000844 hepatocellular carcinoma Toxicity 0.000 title claims 2
- 229940127432 VEGFR3 Inhibitors Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- ATWMPZKVOXOIQK-GOSISDBHSA-N 2-amino-7-[(3r)-3,4-dihydroxy-3-methylbut-1-ynyl]-1-ethyl-3-(1h-imidazol-2-yl)-1,8-naphthyridin-4-one Chemical compound O=C1C2=CC=C(C#C[C@@](C)(O)CO)N=C2N(CC)C(N)=C1C1=NC=CN1 ATWMPZKVOXOIQK-GOSISDBHSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (5)
1. Spoj formule (I),
[image]
naznačen time da R je metoksi ili hidroksil skupina,
ili njegova farmaceutski prihvatljiva sol, naznačen time da je za upotrebu za liječenje hepatocelularnog karcinoma.
2. Spoj za uporabu prema zahtjevu 1, naznačen time da R je metoksi skupina.
3. Spoj za uporabu prema zahtjevu 1, naznačen time da R je hidroksil skupina.
4. Spoj za uporabu prema bilo kojem od patentnih zahtjeva 1 ili 2, naznačen time da je 2-amino-1-etil-7-((3R)-3-hidroksi-4-metoksi-3-metil-but-1-inil)-3-(1H-imidazol-2-il)-1H-[1,8]-naftiridin-4-on.
5. Spoj za uporabu prema bilo kojem od patentnih zahtjeva 1 ili 3, naznačen time da je 2-amino-7-((3R)3,4-dihidroksi-3-metil-but-1-inil)-1-etil-3-(1H-imidazol-2-il)-1,8-naftiridin-4(1H)-on.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261672489P | 2012-07-17 | 2012-07-17 | |
| EP12305866 | 2012-07-17 | ||
| EP13737259.5A EP2874625B1 (en) | 2012-07-17 | 2013-07-16 | Use of vegfr-3 inhibitors for treating hepatocellular carcinoma |
| PCT/EP2013/065029 WO2014012942A1 (en) | 2012-07-17 | 2013-07-16 | Use of vegfr-3 inhibitors for treating hepatocellular carcinoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20171227T1 true HRP20171227T1 (hr) | 2017-10-20 |
Family
ID=49948312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20171227TT HRP20171227T1 (hr) | 2012-07-17 | 2017-08-08 | Upotreba inhibitora vegfr-3 za liječenje hepatocelularnog karcinoma |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US9376432B2 (hr) |
| EP (1) | EP2874625B1 (hr) |
| JP (1) | JP6226981B2 (hr) |
| KR (1) | KR102068860B1 (hr) |
| CN (1) | CN104602691B (hr) |
| AU (1) | AU2013292054B2 (hr) |
| BR (1) | BR112015000942A2 (hr) |
| CA (1) | CA2878987C (hr) |
| CL (1) | CL2015000115A1 (hr) |
| CR (1) | CR20150029A (hr) |
| CY (1) | CY1119415T1 (hr) |
| DK (1) | DK2874625T3 (hr) |
| EA (1) | EA027982B1 (hr) |
| ES (1) | ES2635105T3 (hr) |
| HK (1) | HK1206257A1 (hr) |
| HR (1) | HRP20171227T1 (hr) |
| HU (1) | HUE035712T2 (hr) |
| IL (1) | IL236718A (hr) |
| LT (1) | LT2874625T (hr) |
| MA (1) | MA37821A1 (hr) |
| MX (1) | MX367402B (hr) |
| PH (1) | PH12015500094A1 (hr) |
| PL (1) | PL2874625T3 (hr) |
| PT (1) | PT2874625T (hr) |
| RS (1) | RS56178B1 (hr) |
| SG (1) | SG11201500156SA (hr) |
| SI (1) | SI2874625T1 (hr) |
| TN (1) | TN2015000021A1 (hr) |
| TW (1) | TW201406759A (hr) |
| WO (1) | WO2014012942A1 (hr) |
| ZA (1) | ZA201500182B (hr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2524915A1 (en) * | 2011-05-20 | 2012-11-21 | Sanofi | 2-Amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors |
| WO2014026242A1 (en) | 2012-08-17 | 2014-02-20 | Cancer Therapeutics Crc Pty Limited | Vegfr3 inhibitors |
| US9238644B2 (en) | 2012-08-17 | 2016-01-19 | Cancer Therapeutics Crc Pty Limited | VEGFR3 inhibitors |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2760456B1 (fr) * | 1997-03-05 | 2000-05-12 | Sanofi Sa | Procede de preparation de derives de 2-thienyl-ethylamine |
| US5994367A (en) | 1997-03-07 | 1999-11-30 | The University Of North Carolina At Chapel Hill | Method for treating tumors using 2-aryl-naphthyridin-4-ones |
| CN1191252C (zh) * | 2003-08-11 | 2005-03-02 | 中国药科大学 | 3－位取代的喹诺酮衍生物及其在药学上的应用 |
| AU2004288709B2 (en) * | 2003-11-07 | 2011-01-06 | Novartis Vaccines And Diagnostics, Inc. | Methods for synthesizing quinolinone compounds |
| CN1325494C (zh) * | 2005-08-18 | 2007-07-11 | 中国药科大学 | 3－位取代的萘啶酮类化合物及其制备方法和在制药中的应用 |
| KR100744826B1 (ko) * | 2006-04-05 | 2007-08-01 | 한국화학연구원 | 이미다졸기가 치환된 퀴놀리논 유도체 |
| FR2917412B1 (fr) * | 2007-06-13 | 2009-08-21 | Sanofi Aventis Sa | Derives de 7-alkynyl, 1,8-naphthyridones, leur preparation et leur application en therapeutique |
| WO2009053799A1 (en) * | 2007-10-24 | 2009-04-30 | Glenmark Pharmaceuticals, S.A. | Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| FR2933701A1 (fr) * | 2008-07-08 | 2010-01-15 | Sanofi Aventis | Derives anticancereux, leur preparation et leur application en therapeutique |
| FR2933700B1 (fr) * | 2008-07-08 | 2010-07-30 | Sanofi Aventis | Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique |
| WO2010073078A2 (en) | 2008-12-22 | 2010-07-01 | Orchid Research Laboratories Ltd. | Heterocyclic compounds as hdac inhibitors |
| FR2952934B1 (fr) * | 2009-11-23 | 2012-06-22 | Sanofi Aventis | Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique |
| EP2524915A1 (en) * | 2011-05-20 | 2012-11-21 | Sanofi | 2-Amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors |
-
2013
- 2013-07-16 EP EP13737259.5A patent/EP2874625B1/en active Active
- 2013-07-16 CN CN201380038420.2A patent/CN104602691B/zh active Active
- 2013-07-16 DK DK13737259.5T patent/DK2874625T3/en active
- 2013-07-16 AU AU2013292054A patent/AU2013292054B2/en active Active
- 2013-07-16 LT LTEP13737259.5T patent/LT2874625T/lt unknown
- 2013-07-16 PL PL13737259T patent/PL2874625T3/pl unknown
- 2013-07-16 KR KR1020157003116A patent/KR102068860B1/ko active IP Right Grant
- 2013-07-16 ES ES13737259.5T patent/ES2635105T3/es active Active
- 2013-07-16 US US14/414,209 patent/US9376432B2/en active Active
- 2013-07-16 SG SG11201500156SA patent/SG11201500156SA/en unknown
- 2013-07-16 BR BR112015000942A patent/BR112015000942A2/pt not_active IP Right Cessation
- 2013-07-16 EA EA201590229A patent/EA027982B1/ru not_active IP Right Cessation
- 2013-07-16 HU HUE13737259A patent/HUE035712T2/en unknown
- 2013-07-16 PT PT137372595T patent/PT2874625T/pt unknown
- 2013-07-16 JP JP2015522076A patent/JP6226981B2/ja active Active
- 2013-07-16 RS RS20170806A patent/RS56178B1/sr unknown
- 2013-07-16 SI SI201330745T patent/SI2874625T1/sl unknown
- 2013-07-16 CA CA2878987A patent/CA2878987C/en active Active
- 2013-07-16 WO PCT/EP2013/065029 patent/WO2014012942A1/en active Application Filing
- 2013-07-16 MX MX2015000797A patent/MX367402B/es active IP Right Grant
- 2013-07-16 MA MA37821A patent/MA37821A1/fr unknown
- 2013-07-17 TW TW102125634A patent/TW201406759A/zh unknown
-
2015
- 2015-01-12 ZA ZA2015/00182A patent/ZA201500182B/en unknown
- 2015-01-14 IL IL236718A patent/IL236718A/en active IP Right Grant
- 2015-01-14 PH PH12015500094A patent/PH12015500094A1/en unknown
- 2015-01-15 CL CL2015000115A patent/CL2015000115A1/es unknown
- 2015-01-16 TN TNP2015000021A patent/TN2015000021A1/fr unknown
- 2015-01-22 CR CR20150029A patent/CR20150029A/es unknown
- 2015-07-20 HK HK15106876.9A patent/HK1206257A1/xx unknown
-
2017
- 2017-08-08 HR HRP20171227TT patent/HRP20171227T1/hr unknown
- 2017-08-16 CY CY20171100874T patent/CY1119415T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2013000414A1 (en) | 4-amino-5-fluoro-3- [6- (4 -methylpiperazin- 1 - yl) - 1h - benzimidazol - 2 - yl] - 1h - quinoli n-2-one for use in the treatment of adenoid cystic carcinoma | |
| IL231226A (en) | Compounds and preparations as kinase c-kit inhibitors, pharmaceutical preparations containing them and their use in the preparation of medicines for the treatment of diseases | |
| SA515360469B1 (ar) | مركبات حلقية غير متجانسة لتثبيط إنزيم جلوتاميناز والطرق الخاصة باستخدامها | |
| MX340533B (es) | Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas. | |
| MX2015002177A (es) | Derivados de 1,6- diazabiciclo [3.2,1] octano-7-ona y su uso en el tratamiento de las infecciones bacterianas. | |
| MX367713B (es) | Uso de derivados de pirazolopirimidina para el tratamiento de trastornos relacionados con la fosfoinositida 3-cinasa delta. | |
| IL235659A (en) | History 3, 4 - Dihydro-h2 - Pyrido [1, 2 - a] Pyrazine – 1, 6 - Transformed deion used to treat (among other things) Alzheimer's disease | |
| TN2013000237A1 (en) | Imidazo [4, 5 -c] quinolin- 2 -one compound and its use as pi3 kinase / mtor dual inhibitor | |
| RS54339B1 (en) | NEW ANTIMALARIAN AGENTS | |
| CL2013002177A1 (es) | Compuestos derivados de 9h-purinas y 7h-pirrolo[2,3-d]-pirimidinas sustituidas, inhibidores de la pi3k de clase i y/o mtor; su composicon farmaceutica; su combinacion farmaceutica; y su uso en el tratamiento o la prevencion del cancer o trastornos neurodegenerativos. | |
| MX2014012450A (es) | Compuestos y metodos para tratamiento antivirico. | |
| LT2898885T (lt) | Pirolopirimidino dariniai, skirti naudoti virusinių infekcijų gydymui | |
| IL202505A (en) | 2-oxo-3-benzyl-benzoxazole-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors, drugs containing them and their uses | |
| WO2015021358A3 (en) | Compounds and methods for inhibiting phosphate transport | |
| WO2013164061A8 (en) | Pyrrolotriazinone derivatives | |
| ZA201402907B (en) | Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies | |
| PT2736488E (pt) | Composições farmacêuticas contendo rifaximina, processos para a sua preparação e sua utilização no tratamento de infeções vaginais | |
| GEP201706656B (en) | 2-thiopyrimidinones | |
| MX340574B (es) | Imidazo pirazinas. | |
| IL237636B (en) | 2-(r)-(4-fluoro-2-methyl-phenyl)-4-(s)-(as8)-6-oxo-hexahydro-pyrrolo[1,2-a]pyrazin-2-yl)-piperidine -1- carboxylic acid [1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methylamide or a pharmaceutical acceptable salt thereof for use in the treatment of chronic itching | |
| HRP20171227T1 (hr) | Upotreba inhibitora vegfr-3 za liječenje hepatocelularnog karcinoma | |
| HRP20180386T1 (hr) | Farmaceutski aktivni spojevi | |
| CL2014001323A1 (es) | Compuestos derivados de 3-fenil-isoquinolin-1(2h)-ona, inhibidores de parp-1; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer. | |
| WO2013117503A3 (en) | Pi3k inhibitors for treating fibrotic diseases | |
| EP2709630A4 (en) | PAR1 INHIBITORS FOR USE IN THE TREATMENT OR PREVENTION OF PARAMYXOVIRIDAE INFECTIONS |